[go: up one dir, main page]

WO2002034913A3 - Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof - Google Patents

Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof Download PDF

Info

Publication number
WO2002034913A3
WO2002034913A3 PCT/US2001/031454 US0131454W WO0234913A3 WO 2002034913 A3 WO2002034913 A3 WO 2002034913A3 US 0131454 W US0131454 W US 0131454W WO 0234913 A3 WO0234913 A3 WO 0234913A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid molecules
molecules encoding
protein coupled
coupled receptors
Prior art date
Application number
PCT/US2001/031454
Other languages
French (fr)
Other versions
WO2002034913A2 (en
Inventor
Ming-Hui Wei
Chunhua Yan
Karen A Ketchum
Anibal Cravchik
Francesco Valentina Di
Ellen M Beasley
Original Assignee
Pe Corp Ny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pe Corp Ny filed Critical Pe Corp Ny
Priority to AU2002213061A priority Critical patent/AU2002213061A1/en
Priority to JP2002537883A priority patent/JP2004535756A/en
Priority to CA002425897A priority patent/CA2425897A1/en
Priority to EP01981419A priority patent/EP1330521A2/en
Publication of WO2002034913A2 publication Critical patent/WO2002034913A2/en
Publication of WO2002034913A3 publication Critical patent/WO2002034913A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the Human genome, the GPCR peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the GPCR peptides and methods of identifying modulators of the GPCR peptides.
PCT/US2001/031454 2000-10-24 2001-10-09 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof WO2002034913A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002213061A AU2002213061A1 (en) 2000-10-24 2001-10-09 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
JP2002537883A JP2004535756A (en) 2000-10-24 2001-10-09 Isolated human G-protein coupled receptor, nucleic acid molecule encoding human GPCR protein, and uses thereof
CA002425897A CA2425897A1 (en) 2000-10-24 2001-10-09 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
EP01981419A EP1330521A2 (en) 2000-10-24 2001-10-09 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69482100A 2000-10-24 2000-10-24
US09/694,821 2000-10-24
US78155901A 2001-02-13 2001-02-13
US09/781,559 2001-02-13

Publications (2)

Publication Number Publication Date
WO2002034913A2 WO2002034913A2 (en) 2002-05-02
WO2002034913A3 true WO2002034913A3 (en) 2002-10-31

Family

ID=27105446

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/031454 WO2002034913A2 (en) 2000-10-24 2001-10-09 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof

Country Status (5)

Country Link
EP (1) EP1330521A2 (en)
JP (1) JP2004535756A (en)
AU (1) AU2002213061A1 (en)
CA (1) CA2425897A1 (en)
WO (1) WO2002034913A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002101043A2 (en) * 2001-06-08 2002-12-19 Bayer Aktiengesellschaft Regulation of human ta4 receptor
WO2003020980A2 (en) * 2001-08-28 2003-03-13 Pharmacia & Upjohn Company Single nucleotide polymorphisms diagnostic for schizophrenia
WO2004008153A2 (en) * 2002-07-16 2004-01-22 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with homo sapiens putative neurotransmitter receptor (pnr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000060081A1 (en) * 1999-04-06 2000-10-12 Synaptic Pharmaceutical Corporation Dna encoding orphan receptors
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000060081A1 (en) * 1999-04-06 2000-10-12 Synaptic Pharmaceutical Corporation Dna encoding orphan receptors
WO2001036473A2 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Human g protein-coupled receptors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOROWSKY B. ET AL.: "Trace amines: Identification of a family of mammalian G protein-coupled receptors", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 98, no. 16, 31 July 2001 (2001-07-31), pages 8966 - 8971, XP002185201, ISSN: 0027-8424 *
DATABASE EMBL [online] 2 August 2001 (2001-08-02), "Homo sapiens trace amine receptor 4 (TA4) gene, complete cds.", XP002205531, Database accession no. AF380192 *

Also Published As

Publication number Publication date
WO2002034913A2 (en) 2002-05-02
JP2004535756A (en) 2004-12-02
AU2002213061A1 (en) 2002-05-06
EP1330521A2 (en) 2003-07-30
CA2425897A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
WO2001073029A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2001072841A3 (en) Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2001087980A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002046407A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001072838A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002024892A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
WO2001072839A3 (en) Human g-protein coupled receptors
WO2002034913A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002031146A3 (en) Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
WO2001081409A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002068651A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2001072840A3 (en) Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002079406A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof
WO2002046406A3 (en) Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
WO2002072831A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002066644A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002079229A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002063001A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002079450A3 (en) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2002020757A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002046217A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002024748A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002033086A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002057310A3 (en) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
WO2002024910A3 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2425897

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002537883

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001981419

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001981419

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001981419

Country of ref document: EP